Octagon Capital Advisors »

Fate Therapeutics shares owned by Octagon Capital Advisors

Quarter-by-quarter ownership of Fate Therapeutics (FATE) shares owned by Octagon Capital Advisors from 13F filings

Historical chart of Octagon Capital Advisors investment in Fate Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Fate Therapeutics held by Octagon Capital Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Fate Therapeutics by Octagon Capital Advisors

Quarter filed Position value Share count Share price at filing
2024-03-31 $3.8M 521k 7.34
2022-09-30 $7.4M 331k 22.41